News
Nimbus Therapeutics will host a webcast seminar to discuss the latest data from its HPK1 program on Thursday, June 25, from 11 a.m. to 12 p.m. ET.
The seminar, titled “Novel, Potent, Selective HPK1 Inhibitors Enhance Immune Activation to Inhibit Tumor Growth,” will take place on Tuesday, Nov. 17, from 11 a.m. to 12 p.m. ET.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback